More Cases of Monkeypox Emerge in Portugal as Outbreak Widens
Patients in the confirmed cases have skin lesions and are in stable condition
Infectious Disease
Loss of Smell, Taste Less Likely With Newer COVID-19 Variants
Lower risk for developing chemosensory loss observed with alpha, delta, and omicron variants
FDA Declines EUA Request for Fluvoxamine for COVID-19 Treatment
The totality of the evidence led the FDA to determine that the criteria for issuing an EUA had not been met.
Increasing Impact of HPV Vaccination Seen in the US
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV
The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.
mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients
Vaccine Effectiveness Modest for Children, Teens During Omicron
BNT162b2 vaccine effectiveness against symptomatic infection modest and declined rapidly, was higher after booster dose in teens
Persistent Viral Shedding Common in Hospitalized COVID-19 Patients
Persistent viral shedding associated with in-hospital delirium and increased six-month mortality
Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection
Reduction in viral load from baseline greater with lenacapavir versus placebo among those with multidrug-resistant HIV-1 infection
FDA Issues Safety Alert for COVID-19 Test Over Concerns of False Results
In the safety communication, the FDA noted that the use of this unauthorized test may increase the risk of false results.
